Stay updated on Preventing GvHD in Allo ApoGraft SCT - Clinical Trial
Sign up to get notified when there's something new on the Preventing GvHD in Allo ApoGraft SCT - Clinical Trial page.

Latest updates to the Preventing GvHD in Allo ApoGraft SCT - Clinical Trial page
- Check2 days agoChange DetectedA new revision entry v3.6.3 was added to the Record History and the previous v3.6.2 entry was removed, updating the page's version history.SummaryDifference0.1%

- Check9 days agoChange DetectedA new revision entry v3.6.2 was added to the study history. The v3.6.0 entry was removed, updating the visible revision history to reflect the latest version.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe record history now shows explicit Last verified and Last known status were fields and lists the current revision as v3.6.0, replacing the previous revision v3.5.5.SummaryDifference2%

- Check30 days agoChange DetectedA new revision entry v3.5.5 was added, replacing the previous revision v3.5.4. This is a platform update and does not modify the study record data.SummaryDifference0.1%

- Check52 days agoChange DetectedA new revision entry v3.5.4 has been added to the record history, replacing the previous v3.5.3. This reflects a minor update to the historical record rather than changes to the study data.SummaryDifference0.1%

- Check66 days agoChange DetectedThe record history now lists Revision: v3.5.3, indicating an updated version of the study record metadata.SummaryDifference0.1%

Stay in the know with updates to Preventing GvHD in Allo ApoGraft SCT - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Preventing GvHD in Allo ApoGraft SCT - Clinical Trial page.